Back to top
more

IDEXX Laboratories (IDXX)

(Delayed Data from NSDQ)

$472.35 USD

472.35
432,975

+3.17 (0.68%)

Updated Sep 6, 2024 04:00 PM ET

After-Market: $470.94 -1.41 (-0.30%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (70 out of 249)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

5 Stocks that Outperformed the S&P 500 in Q1

First quarter was quite impressive and we have selected five top-ranked stocks that surpassed the S&P 500 index during the period.

    Varian (VAR) Eclipse Software Tops in International Studies

    Varian Medical Systems, Inc. (VAR) recently announced that its Eclipse treatment planning software has topped in two competitive international plan studies.

      PAREXEL (PRXL) Launches Sensor for Clinical Trial Market

      PAREXEL International Corporation (PRXL), a global biopharmaceutical services company and provider of clinical research and logistics, recently announced the launch of its patient sensor solution.

        AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View

        AngioDynamics Inc. (ANGO), a leading provider of minimally invasive medical devices, reported adjusted earnings of 19 cents per share in the third quarter of fiscal 2017.

          David Bartosiak headshot

          New Zacks Rank Strong Buy Stocks Breaking to Highs

          Today???s Daily Dive included a brief overview of the stellar action on crude oil, including intermediate term targets for the contract.

            Envision (EVHC) Teams Up with Lyft to Focus on Transportation

            Envision Healthcare Corporation (EVHC) recently announced that it has teamed up with on-demand transportation service provider Lyft.

              Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife

              On Mar 29, we issued an updated research report on North Kansas City, MO-based Cerner Corporation (CERN) ??? a leading global provider of healthcare information technology solutions (HCIT).

                Here's Why You Should Steer Clear of Mednax (MD) for Now

                Over the past 6 six months, shares of Mednax (MD) have gained 4.9%., underperforming the 9.8% increase logged by the Zacks categorized Medical - Hospital industry.

                  Intuitive Surgical Hits 52-Week High on Multiple Positives

                  Shares of leading provider of robotic-assisted surgery, Intuitive Surgical, Inc. (ISRG) rallied to a new 52-week high of $770.28 on Mar 28, closing a tad lower at $764.47.

                    3 Medical Device Stocks to Brave Policy Uncertainty

                    We believe stocks with strong fundamentals that also have a significant share of their business overseas may well brace themselves in the on-going conundrum. They will make lucrative additions to your portfolio.

                      IDEXX (IDXX) Poised on Strong Fundamentals, Innovations

                      On Mar 14, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).

                        ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI

                        A new study demonstrates that ABIOMED's flagship Impella 2.5 heart pump can reduce the risk of acute kidney injury during high-risk percutaneous coronary intervention (PCI).

                          Cooper Companies (COO) Receives ISO 15189 Accreditation

                          The Cooper Companies Inc. (COO) announced that its London and Nottingham-based laboratories received the International Organization for Standardization 15189 accreditation.

                            C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain

                            We issued an updated research report on C. R. Bard Inc. (BCR) on Mar 8, 2017.

                              Baxter (BAX) Hits a 52-Week High: What's Driving the Stock?

                              Share price of Baxter International Inc. (BAX), a global medical technology company, rallied to a new 52-week high of $51.43 on Mar 8, eventually closing a bit lower at $51.36.

                                Intersect ENT: FDA Submission of RESOLVE Implant, Stock Up

                                Intersect ENT, Inc (XENT) recently announced the submission of a New Drug Application (NDA) approval with the U.S. FDA for reviewing its investigational RESOLVE steroid releasing implant.

                                  OPKO Health (OPK) Launches Prenatal Testing Tool ClariTest

                                  OPKO Health Inc. (OPK) recently announced the launch of a non-invasive medical test to detect fetal abnormalities.

                                    Meridian (VIVO) to Provide LeadCare Testing System in Africa

                                    Meridian Bioscience, Inc. (VIVO), a renowned life sciences company, recently signed an exclusive distribution agreement with Biofirm Technologies.

                                      TransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4

                                      TransEnterix, Inc. (TRXC) reported a loss of 12 cents per share in the fourth quarter of 2016, wider than the Zacks Consensus Estimate of a loss of 11 cents.

                                        Masimo Announces Availability of RD SedLine Brain Sensors

                                        Masimo Corporation (MASI) recently announced the availability of the RD SedLine EEG sensor, which can be used with the company???s flagship SedLine Brain Function Monitoring technology.

                                          Allscripts (MDRX) Acknowledged by LPP's CDIS Framework

                                          Allscripts Healthcare Solutions, Inc. (MDRX) recently announced that it has been accepted and acknowledged by the NHS London Procurement Partnership (LPP) in its Clinical and Digital Information Systems (CDIS) Framework.

                                            IDEXX (IDXX) Up 5.8% Since Earnings Report: Can It Continue?

                                            IDEXX (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                              Top Ranked Momentum Stocks to Buy for February 14th

                                              Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 14th:

                                                Can the Rally in IDEXX Laboratories (IDXX) Shares Continue?

                                                IDEXX Laboratories, Inc. (IDXX) has been on the move lately as the stock has risen by 16.5% in the past four weeks, and it is currently trading well above its 20-Day SMA

                                                  Looking for a Growth Stock? Why It is Time to Focus on IDEXX Laboratories (IDXX)

                                                  IDEXX Laboratories (IDXX) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.